Streptococcus pyogenes-purpura fulminans as an invasive form of group A streptococcal infection

Ann Clin Microbiol Antimicrob. 2018 Jul 9;17(1):31. doi: 10.1186/s12941-018-0282-9.

Abstract

Background: Streptococcus pyogenes is an uncommon pathogen of purpura fulminans, and the pathogenesis of S. pyogenes-purpura fulminans remains unclear because of paucity of cases. We reported a pediatric case of S. pyogenes-purpura fulminans with literature review of the disease.

Case presentation: A 3-year-old boy showed limping, lethargy and acral gangrene within 24 h. A diagnosis of S. pyogenes-purpura fulminans was made for bacterial isolation from throat and peripheral blood. Intensive therapy led to a survival with amputation of the left distal metatarsal bone, and normal development. The isolated M12 carried no mutation of csrS/R or rgg. Thrombophilia or immunodeficiency was excluded.

Discussion: Twelve-reported cases (9 pediatric and 3 elderly) of S. pyogenes-purpura fulminans started with shock and coagulopathy. Five patients age < 8 years had no underlying disease and survived. One youngest and two immunocompromised patients died.

Conclusion: Streptococcus pyogenes-acute infectious purpura fulminans is a distinctive rare form of aggressive GAS infections.

Keywords: Acute infectious purpura fulminans; Disseminated intravascular coagulation; Invasive group A β-Streptococcus; Protein C deficiency; Streptococcal toxic shock syndrome.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use*
  • Child
  • Child, Preschool
  • Fatal Outcome
  • Female
  • Humans
  • Infant
  • Male
  • Middle Aged
  • Purpura Fulminans / pathology*
  • Purpura Fulminans / therapy*
  • Streptococcal Infections / drug therapy*
  • Streptococcal Infections / pathology*
  • Streptococcus pyogenes / drug effects*
  • Streptococcus pyogenes / pathogenicity*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents